- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- December 2024
- 216 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 170 Pages
United States
From €2377EUR$2,500USD£1,997GBP
- Report
- March 2023
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2023
- 78 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- November 2023
- 172 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- June 2022
- 193 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Book
- February 2021
- 544 Pages
Red biotechnology is a branch of biotechnology that focuses on the medical applications of biotechnology. It is used to develop products and processes that can improve human health and well-being. Red biotechnology includes the development of drugs, vaccines, diagnostics, medical devices, and other medical products. It also includes the development of processes for the production of these products, such as fermentation and cell culture. Red biotechnology is closely related to the fields of biochemistry, molecular biology, and genetics.
Red biotechnology is an important part of the biotechnology industry, as it is used to develop products and processes that can improve human health and well-being. It is used in the development of treatments for a wide range of diseases, including cancer, cardiovascular diseases, and infectious diseases. It is also used in the development of diagnostics and medical devices.
Some companies in the red biotechnology market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development of drugs, vaccines, diagnostics, and medical devices. They are also involved in the development of processes for the production of these products. Show Less Read more